Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CASI Pharmaceuticals (CASI) Shares Outstanding (Weighted Average) (2021 - 2025)

Historic Shares Outstanding (Weighted Average) for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to $15.5 million.

  • Pharmaceuticals' Shares Outstanding (Weighted Average) rose 1469.43% to $15.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $15.5 million, marking a year-over-year increase of 1469.43%. This contributed to the annual value of $2.6 million for FY2024, which is 2673.27% up from last year.
  • Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $15.5 million in Q2 2025, which was up 1469.43% from $690000.0 recorded in Q1 2025.
  • In the past 5 years, Pharmaceuticals' Shares Outstanding (Weighted Average) ranged from a high of $15.5 million in Q2 2025 and a low of $690000.0 during Q1 2025
  • In the last 5 years, Pharmaceuticals' Shares Outstanding (Weighted Average) had a median value of $13.3 million in 2023 and averaged $9.2 million.
  • Over the last 5 years, Pharmaceuticals' Shares Outstanding (Weighted Average) had its largest YoY gain of 2673.27% in 2024, and its largest YoY loss of 9467.73% in 2024.
  • Over the past 5 years, Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $13.6 million in 2021, then crashed by 77.88% to $3.0 million in 2022, then crashed by 32.89% to $2.0 million in 2023, then increased by 26.73% to $2.6 million in 2024, then soared by 505.7% to $15.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $15.5 million for Q2 2025, versus $690000.0 for Q1 2025 and $2.6 million for Q4 2024.